Cerebral Palsy Clinical Trials

A listing of Cerebral Palsy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 164 clinical trials
Asciminib Treatment Optimization in ≥ 3rd Line CML-CP.

The purpose of the study is to optimize the treatment of asciminib in patients with chronic myelogenous leukemia in chronic phase (CML-CP) previously treated with 2 or more Tyrosine Kinase

asciminib
dasatinib
bosutinib
ponatinib
imatinib
  • 0 views
  • 11 Aug, 2022
  • 37 locations
Targeting Chronic Pain in Primary Care Settings Using Behavioral Health Consultants, A Randomized Pragmatic Trial

The purpose of this randomized pragmatic trial is to assess the effect of monthly booster contacts on long-term Brief Cognitive Behavioral Therapy for Chronic Pain (BCBT-CP) pain outcomes

behavior therapy
chronic pain
pain relieving
chronic pain management
  • 13 views
  • 21 Sep, 2022
  • 4 locations
Little ABC: A Randomized Controlled Trial on Effects of Universal Parental Group Support Regarding Infants Aged 12-24 Months

investigators therefore want to study the effects of a modified version of ABC for parents of children 1-2 years (Little ABC) to see if Little ABC can strengthen parenting ability and have effects on children's

  • 0 views
  • 18 Sep, 2022
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase

The study is designed to compare the efficacy of asciminib 80 mg QD versus Investigator selected TKI for the treatment of newly diagnosed, previously untreated patients with Ph+ CML-CP. The

  • 1 views
  • 18 Sep, 2022
  • 128 locations
An Open Label, Single Arm, Extension Trial to Examine Long-term Safety of BI 425809 Once Daily in Patients With Schizophrenia Who Have Completed Previous BI 425809 Phase III Trials (CONNEX-X)

schizophrenia. Participants are in the study for a little more than 1 year. During this time, they visit the study site about 13 times and get about 9 phone calls from the study team. The doctors

  • 0 views
  • 15 Sep, 2022
  • 42 locations
Thriving Together: Supporting Resilience in the Healthcare Workforce

there are few programs and little data for settings outside of hospitals. The program would adapt, implement, and evaluate an evidence-informed peer support program (RISE) in ambulatory practices, rural

Accepts healthy volunteers
  • 0 views
  • 21 Sep, 2022
  • 0 views
  • 11 Aug, 2022
  • 1 location
Mediterranean-like Unprocessed (CLEAN-MED) Diet Intervention Study of the Gut Microbiome of Healthy Adults

saturated fat) to a Mediterranean-like unprocessed foods diet (CLEAN-MED) changes the environment in the intestine. The CLEAN-MED diet includes lots of vegetables, fruits, and whole grains with little

Accepts healthy volunteers
  • 0 views
  • 21 Sep, 2022
  • 1 location
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma

stroke, heart attack and sudden death, in situations that would normally pose little or no risk, such as surgery, general anesthesia or childbirth. Patients with pheochromocytoma may be eligible

metastatic disease
positron emission tomography
18f-fdg
pheochromocytoma
genetic testing
  • 20 views
  • 22 Sep, 2022
  • 1 location
Fissure Closure With the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema; A Multicenter, Prospective Trial (CONVERT)

the target lung lobe to having little to no collateral ventilation. Subjects can then receive Zephyr Valves to achieve atelectasis in the targeted lobe, once AeriSeal has converted the CV+ lobe to a

zephyr
aeriseal
lung volume reduction
  • 22 views
  • 23 Sep, 2022
  • 12 locations